Skip to main content

Advertisement

Table 3 Frequency distribution of drugs deliverers in MDA according to their knowledge about LF and MDA as well as MDA feedback by district

From: Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia

Variable District
Agam District Depok City Batam City
(N = 109) (N = 107) (N = 102)
n % 95% CI n % 95% CI n % 95% CI
A. Knowledge about lymphatic filariasis (LF)
 Knowledge of LFa
  Low 54 49.5 40.2–58.9 58 54.2 44.7–63.5 76 74.5 65.1–82.1
  High 55 50.5 41.1–59.8 49 45.8 36.5–55.4 26 25.5 17.9–34.9
B. Knowledge about MDA
 Knowledge about MDAb
  Low 54 49.5 40.2–58.9 58 54.2 44.7–63.5 71 69.6 59.9–77.8
  High 54 49.5 40.2–58.9 49 45.8 36.5–55.4 31 30.4 22.2–40.1
C. MDA feedback
 Informed about the number receiving or taking LF drugs
  No 56 51.4 42.0–60.7 22 20.6 13.9–29.3 32 31.4 23.1–41.1
  Yes 53 48.6 39.3–58.0 85 79.4 70.7–86.1 70 68.6 58.9–76.9
D. Other
 Perceived adequacy of knowledge to carry out roles and responsibilities in MDA
  Inadequate 10 9.2 5.0–16.3 9 8.4 4.4–15.5 9 8.8 4.6–16.2
  Neutral 8 7.4 3.7–14.1 17 15.9 10.1–24.2 25 24.5 17.1–33.9
  Adequate 91 83.5 75.2–89.4 81 75.7 66.6–83.0 68 66.7 56.9–75.2
 Perception about training received prior to MDA
  Very informative 22 20.2 13.6–28.8 59 55.1 45.6–64.4 36 35.3 26.6–45.1
  Informative 68 62.4 52.9–71.0 38 35.5 27.0–45.1 46 45.1 35.7–54.9
  Less informative 7 6.4 3.1–12.9 4 3.7 1.4–9.6 18 17.7 11.4–26.4
  No training 12 11.0 6.3–18.5 6 5.6 2.5–12.0 2 2.0 0.5–7.6
  1. aKnowledge about LF is based on three variables: (i) know that worm is the cause of LF; (ii) know that mosquitoes transmit LF; and (iii) know that LF is preventable. Low level of knowledge is assigned to those scoring less than median of the distribution and high level of knowledge is assigned to those scoring the same as median or above
  2. bKnowledge about MDA is based on six variables: knowledge that (i) all LF drugs should be taken; (ii) pregnant women should not take LF drugs; (iii) children under two years old should not take LF drugs; (iv) severely undernourished children should not take LF drugs; (v) people aged more than 75 years old should not take LF drugs; and (vi) severely ill people should not take LF drugs. Low level of knowledge is assigned to those scoring less than median and high level of knowledge is assigned to those scoring the same as median or above